Urticaria is a disabling skin condition characterised by recurrent, raised, pruritic lesions, lasting between one hour and several days that settle without disruption of the epidermal barrier. Angioedema often coexists with urticaria but can also occur independently. It is timely to review current evidence for various treatments and their potential role in management of this troublesome condition given recent advances in research and availability of new medications.
This document has been developed by the ASCIA CSU Working Party in 2015:
Prof Constance H Katelaris (Chair), Dr WIlliam SMith (Deputy Chair), Dr James Choi, Dr Katie Frith, Dr Wun Yee Lau, Dr Richard Nolan, Dr Katrina Randall, A/Prof Robert Stirling, Dr Brynn Wainstein.
© ASCIA 2015
ASCIA information is reviewed by the ASCIA membership and represents the available published literature at the time of review.
The content of this document is not intended to replace professional medical advice and any questions regarding a medical diagnosis or treatment should be directed to a medical practitioner.
Medical practitioners should check the product information supplied by the manufacturer before prescribing medications that are mentioned in this document.
Development of this document was supported by an educational grant from Novartis.
The content of this document is not influenced by any commercial organisations.
Content updated November 2015